Media Room

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

25 April 2024
Virax Biolabs, Press Release

view
Virax Biolabs to Participate at ESCMID Global 2024

16 April 2024
Virax Biolabs, Press Release

view
Post-Viral Syndromes and the Utility of T-cell Diagnostics

10 April 2024
Dr. Nigel McCracken, Clinical Lab Products

view
James Foster CEO & Nigel McCracken COO - Virax Biolabs

8 January 2024
Don Davis PhD, Life Science Success Podcast

view
Virax Biolabs Partners With University of Manchester, Northern Care Alliance on Long COVID Study

4 January 2024
Staff Reporter, 360Dx

view
Identifying Post-Viral Syndromes Such as Long COVID

27 December 2023
John Parkinson, Contagion Live

view
Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

21 December 2023
Virax Biolabs, Press Release

view
Virax Biolabs' CEO James Foster Issues Letter to Shareholders

18 December 2023
Virax Biolabs, Press Release

view
Dr. Nigel McCracken, Ph.D. - Chief Operating Officer, Virax Biolabs

22 November 2023
Ira Pastor, Progress, Potential, And Possibilities

view
16 Clinical Laboratory Predictions for 2024

21 November 2023
Chris Wolski, Clinical Lab Products

view
“Regulatory reforms and incentives implemented by Middle Eastern countries have simplified market entry for life sciences companies”

4 October 2023
Ayesha Siddiqui, BioSpectrum Asia

view
Could a Predictive Test Fuel a Diagnostic Revolution?

2 October 2023
Chris Wolski, Clinical Lab Products

view
T Cell Secrets

15 September 2023
James Foster, ID Transmission

view
Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

12 September 2023
Virax BIolabs, Press Release

view
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

1 September 2023
Virax Biolabs, Press Release

view
Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

18 July 2023
Virax Biolabs, Press Release

view
Abu Dhabi, Dubai Serve as Gateway to International Markets for Biopharma

17 July 2023
Lisa Munger, BioSpace

view
How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing

13 July 2023
Chris Leidl, Rx for Biotech

view
Better Health Care Tests, Faster

15 June 2023
Andy Oram, Healthcare IT Today

view
Virax Biolabs' CEO James Foster Issues Letter to Shareholders

14 June 2023
Virax Biolabs, Press Release

view
Virax Biolabs readies clinical performance study of ViraxImmune Platform

1 June 2023
Leonard Zehr, BioTuesdays

view
Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

4 May 2023
Virax Biolabs, Press Release

view
Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

19 April 2023
Virax Biolabs, Press Release

view
Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

8 March 2023
Virax Biolabs, Press Release

view
Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

7 March 2023
Virax Biolabs, Press Release

view
VRAX: INITIATION: Innovative Biotechnology Company Developing A Potentially Groundbreaking Immunology Platform Based Around Proprietary T-Cell Testing Technology

16 February 2023
Thomas Kerr, CFA, Zacks Small Cap Research

view
Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances (feat. James Foster, CEO)

27 January 2023
Eleanor Malone, Scrip Pharma Intelligence

view
Molecular Diagnostics Adapts to Evolving Diseases (feat. Dr. Tomasz George, CSO)

2 February 2023
Anjali A. Sarkar, PhD, Genetic Engineering & Biotechnology News

view
Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

7 February 2023
Virax Biolabs, Press Release

view
Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

6 February 2023
Virax Biolabs, Press Release

view
Virax Biolabs' CEO James Foster Issues Letter to Shareholders

2 February 2023
Virax Biolabs, Press Release

view
Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

4 January 2023
Virax Biolabs, Press Release

view
Determining Long Term Immunity May Aid in Understanding Vaccine Efficacy – Interview with Dr. Tomasz George, CSO

22 December 2022
John Parkinson, Contagion Live

view
Virax Biolabs Preparing T-Cell Testing Platform to Provide Consumers With Immune Status Info

16 December 2022
Kelsy Ketchum, 360 Dx

view
COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

6 December 2022
Virax Biolabs, Press Release

view
Assessing Adaptive Immune Responses to Viruses to Inform Decisions about Vaccinations with Dr. Tomasz George

1 December 2022
Karen Jagoda, Empowered Patient Podcast

view
In Every Crisis There Is An Opportunity – Interview with Chief Executive, James Foster

23 November 2022
Tom Hickey, Med Tech Gurus

view
Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

15 November 2022
Virax Biolabs, Press Release

view
Virax Biolabs Announces Closing of $3.8 Million Private Placement

8 November 2022
Virax Biolabs, Press Releases

view
Virax Biolabs Announces $3.8 Million Private Placement

4 November 2022
Virax Biolabs, Press Release

view
Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

3 November 2022
Virax Biolabs, Press Releases

view
Virax Biolabs Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

26 October 2022
Virax Biolabs, Press Releases

view
Monkeypox Diagnosis and Immune Profiling Using Proprietary T-cell Test Technology

30 September 2022
Radio Interview, Health Professional Radio

view
Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

22 September 2022
Virax Biolabs, Press Releases

view
Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit

20 September 2022
Virax Biolabs, Press Releases

view
Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

12 September 2022
Virax Biolabs, Press Releases

view
Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

6 September 2022
Virax Biolabs, Press Releases

view
Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

16 August 2022
Virax Biolabs, Press Releases

view
Benzinga Interview with Chief Executive, James Foster

4 August 2022
Video Interview, Benzinga

view
Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

26 July 2022
Virax Biolabs, Press Releases

view
Virax Biolabs Bucks the Market Trend

26 July 2022
Video Interview, Proactive

view
Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

21 July 2022
Virax Biolabs, Press Releases

view
Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering

20 July 2022
Virax Biolabs, Press Releases

view
Virax Biolabs Announces the Formation of Advisory Board of Industry Leaders

31 May 2022
Virax Biolabs, Press Releases

view
Virax Biolabs Introduces New Board of Directors, Announces Members

17 May 2022
Virax Biolabs, Press Releases

view
Virax Biolabs Receives Ethical Approval for its Virax Immune COVID-19 Analytical Performance Study from the SBEBO Foundation for the Assessment of Ethics of Biomedical Research

9 May 2022
Virax Biolabs, GlobeNewswire

view
Virax Biolabs Announces the Appointment of Jason D. Davis as Chief Financial Officer

28 April 2022
Virax Biolabs, Press Release

view
Common cold may protect against SARS-CoV-2 infection and lead the way to new vaccines

14 January 2022
Katharine Lang, Medical News Today

view
EXPLAINED: You May Never Forget The Omicron Variant, Here's Why Your T Cells Certainly Won't Anytime Soon

31 December 2021
Kenneth Mohanty, News 18

view
Beyond the spike: Are T cell COVID-19 vaccines the future?

20 December 2021
Debbie Lambert, Medical News Today

view
Sales of PPE in the UK overtake sandwiches with the masks and hand sanitiser industry now worth more than £8.7BILLION

21 September 2020
Jack Elsom, Daily Mail

view
Coronavirus warning: The 5 most likely places to catch coronavirus in an office

9 September 2020
Georgina Laud, Express

view
Experts reveal ‘Covid hotspots’ in the office – and how to limit your risk

7 September 2020
Natalie Morris, Metro

view
Face coverings to be made compulsory on public transport in England

4 June 2020
Rowena Mason, The Guardian

view

Media Room

Virax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024

Virax Biolabs to Participate at ESCMID Global 2024

Post-Viral Syndromes and the Utility of T-cell Diagnostics

James Foster CEO & Nigel McCracken COO - Virax Biolabs

Virax Biolabs Partners With University of Manchester, Northern Care Alliance on Long COVID Study

Identifying Post-Viral Syndromes Such as Long COVID

Virax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID Patients

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Dr. Nigel McCracken, Ph.D. - Chief Operating Officer, Virax Biolabs

16 Clinical Laboratory Predictions for 2024

“Regulatory reforms and incentives implemented by Middle Eastern countries have simplified market entry for life sciences companies”

Could a Predictive Test Fuel a Diagnostic Revolution?

T Cell Secrets

Virax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts Webinar

Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum

Virax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory Facilities

Abu Dhabi, Dubai Serve as Gateway to International Markets for Biopharma

How Virax Biolabs is Developing a Potentially Game-Changing Immunology Platform for T-Cell Testing

Better Health Care Tests, Faster

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Virax Biolabs readies clinical performance study of ViraxImmune Platform

Virax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science Park

Virax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing Kits

Virax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit

VRAX: INITIATION: Innovative Biotechnology Company Developing A Potentially Groundbreaking Immunology Platform Based Around Proprietary T-Cell Testing Technology

Scrip Asks…What Does 2023 Hold For Biopharma? Part 5: Technological Advances (feat. James Foster, CEO)

Molecular Diagnostics Adapts to Evolving Diseases (feat. Dr. Tomasz George, CSO)

Virax Biolabs Group Limited Announces Purchase Order to Launch COVID-19 and Influenza A+B Antigen Combo Rapid Tests with Cosmos Health (NASDAQ:COSM)

Virax Biolabs to Present at the 2023 BIO CEO & Investor Conference

Virax Biolabs' CEO James Foster Issues Letter to Shareholders

Virax Biolabs Introduces Human Papillomavirus ("HPV") Test Kit

Determining Long Term Immunity May Aid in Understanding Vaccine Efficacy – Interview with Dr. Tomasz George, CSO

Virax Biolabs Preparing T-Cell Testing Platform to Provide Consumers With Immune Status Info

COVID-19 Rapid Antigen Test Distributed By Virax Biolabs Receives Emergency Use Authorization in the United States

Assessing Adaptive Immune Responses to Viruses to Inform Decisions about Vaccinations with Dr. Tomasz George

In Every Crisis There Is An Opportunity – Interview with Chief Executive, James Foster

Virax Biolabs Appoints Richard Pallin as the Vice President of In Vitro Diagnostic Sales

Virax Biolabs Announces Closing of $3.8 Million Private Placement

Virax Biolabs Announces $3.8 Million Private Placement

Virax Biolabs Introduces RSV-Influenza-COVID Triple Virus Antigen Rapid Test Kit

Virax Biolabs Announces Initiation of its Virax Immune COVID-19 Analytical Performance Study

Monkeypox Diagnosis and Immune Profiling Using Proprietary T-cell Test Technology

Virax Biolabs Group Limited Announces Distribution Agreement to Market Monkeypox Virus Real-Time PCR Detection Kit with Cosmos Holdings Inc.

Virax Biolabs Introduces Monkeypox Virus Antigen Rapid Test Kit

Virax BioLabs Presents at H.C. Wainwright's 24th Annual Global Investment Conference

Virax Biolabs Group Limited to Present at H.C. Wainwright's 24th Annual Global Investment Conference in New York, NY

Virax Biolabs Announces NASDAQ Closing Bell Ringing to Celebrate Initial Public Offering

Benzinga Interview with Chief Executive, James Foster

Virax Biolabs Introduces Monkeypox and Varicella-Zoster Viruses Real-Time PCR Detection Kit

Virax Biolabs Bucks the Market Trend

Virax Biolabs Group Limited Completes Initial Public Offering; Shares Begin Trading Today on NASDAQ Capital Market as VRAX

Virax Biolabs Group Limited Announces Pricing of $6.75 Million Initial Public Offering

Virax Biolabs Announces the Formation of Advisory Board of Industry Leaders

Virax Biolabs Introduces New Board of Directors, Announces Members

Virax Biolabs Receives Ethical Approval for its Virax Immune COVID-19 Analytical Performance Study from the SBEBO Foundation for the Assessment of Ethics of Biomedical Research

Virax Biolabs Announces the Appointment of Jason D. Davis as Chief Financial Officer

Common cold may protect against SARS-CoV-2 infection and lead the way to new vaccines

EXPLAINED: You May Never Forget The Omicron Variant, Here's Why Your T Cells Certainly Won't Anytime Soon

Beyond the spike: Are T cell COVID-19 vaccines the future?

Sales of PPE in the UK overtake sandwiches with the masks and hand sanitiser industry now worth more than £8.7BILLION

Coronavirus warning: The 5 most likely places to catch coronavirus in an office

Experts reveal ‘Covid hotspots’ in the office – and how to limit your risk

Face coverings to be made compulsory on public transport in England